Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC

Clinical trial NCT03410615 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03410615
Sponsor: Canadian Cancer Trials Group
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oropharyngeal Squamous Cell Carcinoma

Start date: 2018-05-28
Primary completion: 2026-01-09
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.